The study, published in the American Journal of Infection Control, focused on 10 studies covering 11 cases of possible or confirmed transmission of the virus in healthcare settings, where gaps in care were identified in all events.
The virus can survive for at least two days on hospital surfaces and can also be transferred through vomit and diarrhea. MERS-CoV is present for 16 days in respiratory specimens and stool, and up to 13 days in urine.
“Patients with confirmed or suspected MERS-CoV infection should be cared for under contact and droplet precautions until testing results,” the study’s authors wrote.
Further study is needed on if the infection control gaps that led to MERS-CoV transmission in healthcare settings were due to the use of personal protective equipment, hand hygiene, procedures, environmental cleaning or triage.
More articles on MERS:
CDC Updates Interim MERS Infection Prevention Recommendations
Third MERS Infection Confirmed in U.S.
How Community Hospital Used Technology to Contain MERS
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
